Key Metrics
3.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.85
5-Year SI
5-year SI
- N/A 2-year SI
- 0.83 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Pharmacology
SJR
- Q3 Pharmacology
- Q3 Internal Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.92
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Obesity
- Type 2 diabetes
- Liver disease
- Curcumin
- Metabolic syndrome
- Insulin resistance
- Cross-sectional study
- Overweight
- Western blot
- Randomized controlled trial
- Berberine
- Psoriasis
- Fatty liver
- Anemia
- Type 2 Diabetes Mellitus
- Blood pressure
- Electromagnetic field
- Oxidative stress
- Melanoma
- Metformin
Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 16 |
| Article Processing Charges | USD 2836 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
First-Trimester Triglyceride-Glucose Index and Triglyceride/High-Density Lipoprotein Cholesterol are Predictors of Gestational Diabetes Mellitus Among the Four Surrogate Biomarkers of Insulin Resistance.
- 1 Apr 24
- Diabetes, metabolic syndrome and obesity : targets and therapy
-
Full paper
Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients - Real World Study.
- 1 Apr 24
- Diabetes, metabolic syndrome and obesity : targets and therapy
-
Full paper
Diversities of Mechanism in Patients with VHL Syndrome and diabetes: A Report of Two Cases and Literature Review.
- 1 Apr 24
- Diabetes, metabolic syndrome and obesity : targets and therapy
-
Full paper
Butyrate and Propionate are Negatively Correlated with Obesity and Glucose Levels in Patients with Type 2 Diabetes and Obesity.
- 1 Apr 24
- Diabetes, metabolic syndrome and obesity : targets and therapy
-
Full paper
Effect of Sarcopenia on 10-Year Risk of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.
- 1 Apr 24
- Diabetes, metabolic syndrome and obesity : targets and therapy
-
Full paper
Metabolic Syndrome and Tendon Disease: A Comprehensive Review.
- 1 Apr 24
- Diabetes, metabolic syndrome and obesity : targets and therapy
Scite analysis
Powered by scite_
2.7k articles received 26.5k citations see all
- 1,525 Supporting
- 23,733 Mentioning
- 301 Contrasting
Editorial notices
- 3 Retractions
- 0 Withdrawals
- 0 Corrections
- 21 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
43%
4 to 6 months
51%
7 to 9 months
5%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy been actively publishing?
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy has been in operation since 2008 till date.
What is the publishing frequency of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ?
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy published with a Continuous publication frequency.
How many articles did Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy publish last years ?
In 2023, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy published 335 articles.
What is the eISSN & pISSN for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ?
For Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy,eISSN is 1178-7007 and pISSN is1178-7007.
What is Citescore for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ?
Citescore for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 3.5.
What is SNIP score for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ?
SNIP score for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 0.92.
What is the SJR for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ?
SJR for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is Q3.
Who is the publisher of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ?
DOVE MEDICAL PRESS LTD is the publisher of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.